Assoc. Prof. Dr. Barbara De Filippis is an accomplished scholar in pharmaceutical chemistry whose career reflects sustained excellence in research, teaching, and scientific leadership. With a rigorous academic foundation in pharmaceutical sciences supported by advanced research qualifications, she has cultivated deep expertise in the design, synthesis, and evaluation of bioactive molecules. Her professional trajectory includes extensive experience in academic research environments, where she has contributed to and coordinated laboratory activities, guided research teams, and played a central role in advancing innovative scientific projects. Her work spans molecular design, medicinal chemistry, and pharmaceutical analysis, contributing to the development of compounds with potential therapeutic relevance. She has been an active participant in national and international research collaborations, integrating multidisciplinary approaches that strengthen the impact and visibility of her scientific contributions. Her publication record, comprising numerous peer-reviewed articles indexed in leading scientific databases, is supported by a robust citation profile and a significant h-index, underscoring both productivity and influence within the research community. She has consistently demonstrated commitment to high-quality scholarship through ongoing contributions to the scientific literature, active engagement in research networks, and participation in scholarly dissemination. Her career is further distinguished by professional recognitions and academic qualifications that affirm her disciplinary expertise and long-standing dedication to pharmaceutical chemistry. Through her combined strengths in research innovation, academic service, and collaborative leadership, Assoc. Prof. Dr Barbara De Filippis exemplifies the profile of an outstanding researcher whose continued work promises further advancements in medicinal chemistry and related scientific fields.
Profiles: Scopus | ORCID
Featured Publications
1. Kazimierczak, P., Balaha, M., Palka, K., Wessely-Szponder, J., Wojcik, M., di Giacomo, V., De Filippis, B., & Przekora, A. (2025). Macroporous hydroxyapatite-based bone scaffolds loaded with CAPE derivatives: A strategy to reduce oxidative stress and biofilm formation. Materials, 18.
2. De Filippis, B., Agamennone, M., Ammazzalorso, A., Amoroso, R., Giampietro, L., Maccallini, C., Sağlık, B. N., De Simone, C., Zuccarini, M., Kaplancıklı, Z. A., et al. (2025). Discovery and evaluation of novel sulfonamide derivatives targeting aromatase in ER+ breast cancer. Pharmaceuticals, 18.
3. De Filippis, B., Della Valle, A., Ammazzalorso, A., Maccallini, C., Tesse, G., Amoroso, R., Mollica, A., & Giampietro, L. (2024). Azobenzene as multi-targeted scaffold in medicinal chemistry. Molecules, 29.
4. Tesse, G., Tolomeo, A., De Filippis, B., & Giampietro, L. (2024). Radiolabeled probes from derivatives of natural compounds used in nuclear medicine. Molecules, 29.
5. Maccallini, C., Budriesi, R., De Filippis, B., & Amoroso, R. (2024). Advancements in the research of new modulators of nitric oxide synthases activity. International Journal of Molecular Sciences, 25.
Assoc. Prof. Dr Barbara De Filippis advances scientific innovation through the design and development of novel pharmaceutical compounds that address critical therapeutic needs and strengthen translational research. Her contributions enhance drug discovery processes, support healthier societies, and foster meaningful progress in medicinal chemistry with potential global impact.